FLUTAMIDE (Cipla USA Inc.)


Welcome to the PulseAid listing for the FLUTAMIDE drug offered from Cipla USA Inc.. This Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cipla USA Inc.
NON-PROPRIETARY NAME: FLUTAMIDE
SUBSTANCE NAME: FLUTAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-09-21
END MARKETING DATE: 0000-00-00


FLUTAMIDE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFLUTAMIDE from Cipla USA Inc.
LABELER NAME: Cipla USA Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 125(mg/1)
START MARKETING DATE: 2016-09-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69097-915_8c90da76-d928-486c-92d1-576e8f4d137d
PRODUCT NDC: 69097-915
APPLICATION NUMBER: ANDA075780

Other FLUTAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Flutamide
Cipla USA Inc.FLUTAMIDE
Golden State Medical Supply, Inc.Flutamide
Par Pharmaceutical, Inc.Flutamide
Teva Pharmaceuticals USA, Inc.Flutamide